EFFECTIVENESS AND COST OF ECULIZUMAB ON PATIENTS WITH ATYPICAL (SHUA), URENIC AND HAEMOLITIC SYNDROME, WITH ENLARGEMENT OF THE FREQUENCY OF ADMINISTRATION

EFFECTIVENESS AND COST OF ECULIZUMAB ON PATIENTS WITH ATYPICAL (SHUA), URENIC AND HAEMOLITIC SYNDROME, WITH ENLARGEMENT OF THE FREQUENCY OF ADMINISTRATION